Prestige Consumer Healthcare (PBH) Revenue Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) Revenue Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 2.22% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 4.22% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.31% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 9.51% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.40% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 28.43% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 8.98% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.95% |
| Sep 30, 2025 | -1.78% |
| Jun 30, 2025 | -3.43% |
| Mar 31, 2025 | 3.57% |
| Dec 31, 2024 | 1.89% |
| Sep 30, 2024 | 0.90% |
| Jun 30, 2024 | -0.25% |
| Mar 31, 2024 | 5.22% |
| Dec 31, 2023 | 5.79% |
| Sep 30, 2023 | 6.44% |
| Jun 30, 2023 | 6.78% |
| Mar 31, 2023 | 4.40% |
| Dec 31, 2022 | 4.48% |
| Sep 30, 2022 | 6.71% |
| Jun 30, 2022 | 6.07% |
| Mar 31, 2022 | 3.46% |
| Dec 31, 2021 | 4.37% |
| Sep 30, 2021 | 4.89% |
| Jun 30, 2021 | 1.96% |
| Mar 31, 2021 | -2.43% |